Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
approved publishing date : 2022 - 01 - 19 save search
Denison Announces 22.5% Owned McClean Lake Operation Granted Approval to Expand Tailings Management Facility
Published: 2022-01-19 (Crawled : 23:00) - prnewswire.com
CCJ | $48.68 2.94% -0.99% 3.6M
|
Non-Energy Minerals
|
| O: 1.6%
H: 1.85%
C: -3.47%
granted approval grant
Extreme Biodiesel, Inc. The Company’s Board of Directors has approved the motion to immediately terminate the Reg A
Published: 2022-01-19 (Crawled : 17:00) - globenewswire.com
XTRM | $0.0001 0.0% 11M
|
Manufacturing
|
| O: -3.33%
H: 62.07%
C: 31.03%
media
ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis
Published: 2022-01-19 (Crawled : 14:00) - biospace.com/
CCXI | News | $51.99 -0.04%
|
Health Technology
|
| O: -1.87%
H: 3.12%
C: -7.84%
tavneos treatment avacopan approval
Qilian International Holding Group Limited Receives Approval for the Sale of its Newly Developed Nitrofurantoin Enteric-coated Tablets
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
QLI | $0.76 -4.32% 15K
|
Manufacturing
|
| O: 2.81%
H: 0.39%
C: -2.73%
approval group
Nevro Announces FDA Approval for Expanded Labeling for its 10 kHz High Frequency Spinal Cord Stimulation System for Treatment of Non-Surgical Refractory Back Pain (NSRBP)
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
NVRO | $12.79 4.24% 0.0% 410K
|
Health Technology
|
| O: -2.27%
H: 1.74%
C: -2.59%
treatment fda fda approval spinal cord approval system
Algernon Pharmaceuticals Files for Clinical Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
Published: 2022-01-19 (Crawled : 12:30) - globenewswire.com
AGNPF | $0.0716 178.69% 12K
|
Health Technology
|
| O: 1.33%
H: 1.73%
C: -14.06%
als trial approval stroke phase 1 phase 2 phase 3
Relief Reports US Collaboration Partner Announces Expansion of Aviptadil US Expanded Access & Right to Try Programs for Patients w/COVID-19 Respiratory Failure who've Exhausted All Approved Therapies
Published: 2022-01-19 (Crawled : 10:00) - biospace.com/
RLFTF | $1.45 11.45% 1.3K
|
n/a
|
| O: 1.51%
H: 3.09%
C: -1.37%
RLFTY | $1.4006 733.33% 100
|
n/a
|
| O: -6.53%
H: 3.29%
C: 3.29%
covid-19 aviptadil expansion program respiratory covid report collaboration
Alcanna Inc. Receives Final Court Order Approving Proposed Plan of Arrangement with Sundial Growers Inc.
Published: 2022-01-19 (Crawled : 03:00) - globenewswire.com
SNDL | $2.075 10.37% 9.4% 4.9M
|
Process Industries
|
| O: 1.1%
H: 0.4%
C: -5.72%
order
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.